Vystar Corp. (OTCQB: VYST) is the majority owner of Rotmans Furniture and Carpet and environmentally friendly technologies and products to improve lives, such as RxAir UV light air purification products, Fluid Energy Solutions and Vytex Natural Rubber Latex.
The company announced that its Board of Directors has approved a plan to spin-off part of its RxAir air purification business as a separate, independent, publicly traded company. Vystar desires to set record and ex-dividend dates shortly, complete the spin-off and commence trading of RxAir in the first part of 2020.
Create a publicly traded subsidiary called RxAir, Inc. encompassing the UV400 air purifier product and related intellectual property (IP), tooling, websites and other assets, which will focus on the growth opportunities in the growing residential, healthcare and commercial markets.
Contract with an outside entity which will control 51% interest in RxAir, Inc., with an investment of $3-$5 million in production, tooling, inventory, and operations needed to run RxAir.
Vystar plans to award 39.1% of the RxAir shares as a pro-rata dividend to Vystar shareholders as of the designated record date.
The company will retain 9.99% of RxAir shares for Vystar Corporation.
Vystar anticipates the new entity will have a market capitalization of $10 million based on capital, assets and market track record and further anticipates announcing the ex -dividend date in the next few weeks, where the ex-dividend date would be set 60 days following the announcement.
Vystar is the exclusive creator of Vytex, a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows.
We will be issuing a feature tiny float NASDAQ report Wednesday 10-23-19 at 9:25 AM Eastern. Be sure you downloaded our APP or within the USA, subscribed to our text alerts and receive our stock reports the minute they are issued ahead of the crowd. Text the word “traders” to the short code phone number 25827
Titan Medical Inc. (NASDAQ: TMDI) is a Canadian public company, headquartered in Toronto, Ontario, that also trades on the Toronto Stock Exchange (TMD). Titan is developing the SPORT™ (Single Port Orifice Robotic Technology) Surgical System for use in minimally invasive surgery (“MIS”) that is expected to be commercially available in 2019. Titan’s robotic surgical system is being designed to expand robotic surgery into areas that are currently under serviced. This will allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Currently, the most common medical procedures for which robotic systems are used are hysterectomies and prostatectomies. Titan plans to expand the scope and obtain approval for various surgical procedures.
The company just announced today that it has filed and been receipted for an amended and restated preliminary short form prospectus with securities regulators in the provinces of Ontario, British Columbia and Alberta. Titan has also filed a corresponding registration statement on Form F-10 with the United States Securities and Exchange Commission under the U.S.-Canada Multijurisdictional Disclosure System. Each of these filings is in connection with a proposed marketed offering of units of the Company for total gross proceeds of a minimum of US$15,000,000 and a maximum of US$25,000,000.
It is expected that closing of the Offering will occur on or about October 24, 2019.
The Company is withdrawing all forecasts with respect to the cost and timing of the development of its robotic surgical system beyond the fourth quarter of 2019 because its lack of financing has caused its primary product development supplier to limit the development work on the Company’s robotic surgical system. This supplier has also terminated the employment or engagement of a significant number of the employees and contractors who had been working with the supplier on the development of the Company’s robotic surgical system.
Additionally, the Company’s relationship with another service provider has deteriorated as the service provider, on the one hand, has noted concerns about the Company’s inability to fully pay invoices while the Company, on the other hand, has expressed dissatisfaction with the quality of the work performed by the service provider.
The company has indicated that the proceeds from the offering will be used to rehire employees and resume product development.
The industrial hemp marketplace is expected to top $23 Billion by 2023. Limitless Venture Group, Inc. (OTC PINK: LVGI), has refocused its efforts toward industrial hemp related operations including cultivation, processing, product development, market distribution, and research. Their focus is on farming, testing, building supplies, plastics, fuels, and other research identified opportunities.
Through its wholly-owned subsidiary, Summit Harbor Holdings, Inc. (SHHI), the company just announced that it has signed a Joint Venture agreement with HayMap.com to create Green Prizm Technologies, LLC., which will utilize the fundamental code of HayMap to create HempLink.app, a new app that will revolutionize the industrial hemp marketplace.
The massive potential in the hemp market has farmers and other hemp entrepreneurs jumping into this fragmented and sometimes predatory market due to novice brokers that are trying to get rich quick and do not care about product quality, and have no incentive to resolve issues when they occur. With HempLink.app, farmers, processors and hemp/CBD manufacturers will be able to trade and transact products and services in a trusted, secure and transparent online market. HempLink.app will verify all participants in the market as well as provide a peer to peer review system to provide participants in the transaction with the assurance they are receiving the quality products and services they expect.
Simlatus Corporation (OTC PINK: SIML) announced recently that certifications and manufacturing processes are initiated to commence the manufacturing and delivery pursuant the purchase orders for the CBD Extraction Systems. The company’s subsidiary, Proscere Bioscience Inc., received purchase orders for delivery of 14 CBD Extraction Systems in value of $24M.
In September, the company said it was finalizing the delivery of 14 CBD Extraction Systems in value of $24M. Further negotiations are taking place with various groups for additional systems. These are very expensive systems that require a large space to accommodate all of the features inclusive of the Cold-Water CBD Extraction equipment combined with the Alcohol CBD Extraction systems. Certification for C1D1, and State regulations are a part of the process prior to acceptance of any deposits and cash from the clients.
In conjunction with the September announcement, the company reported that between March and August of this year it has prepaid 5 notes for a total principal, interest and penalties of over $2M.
The company operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry. Proscere Bioscience manufactures the first commercial industry standard cold-water CBD extraction system for medical grade cannabis utilization, along with their aeroponic commercial grade technology control containers for government food-safety programs, commercial and medical grade CBD. Satel Group is the premier high-rise DirecTV providers in the San Francisco metropolitan area, and is now expanding both DirecTV and Internet services across the SF Bay Area. Simlatus manufactures its own proprietary systems for the major broadcast studios, such as Warner Bros., Fox News, CBS and DirecTV. Its video technology is the major system used for underwater oil exploration in the world.
Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TNS LLC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES
The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email firstname.lastname@example.org. TNS LLC provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS.
TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document.
TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.
For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: email@example.com
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Traders News Source